Document is current
Any future updates will be listed below
-
Authors
Sayer, Avan A. https://orcid.org/0000-0003-1283-6457
Cooper, Rachel https://orcid.org/0000-0003-3370-5720
Arai, Hidenori
Cawthon, Peggy M.
Ntsama Essomba, Marie-Josiane https://orcid.org/0000-0002-3417-3351
Fielding, Roger A.
Grounds, Miranda D. https://orcid.org/0000-0002-4530-9402
Witham, Miles D. https://orcid.org/0000-0002-1967-0990
Cruz-Jentoft, Alfonso J. https://orcid.org/0000-0001-7628-4861
- License Information
-
More Information
Article History
Accepted: 12 August 2024
First Online: 19 September 2024
Competing interests
: A.A.S. reports research grant funding from the National Institute for Health and Care Research UK, UK Research and Innovation, a research collaboration agreement with Regeneron Pharmaceuticals and a previous Pfizer Investigator Initiated Research Grant. R.C. reports research grant funding from the National Institute for Health and Care Research UK and UK Research and Innovation. H.A. has no funding or other conflicts of interest to disclose. P.M.C. is a consultant to and owns stock in Myocorps. M.-J.N.E. has no funding or other conflicts of interest to disclose. R.A.F. reports grants from the National Institutes of Health and USDA Agricultural Research Service; grants and personal fees from Axcella Health, Juvicell, Inside Tracker and Biophytis; and personal fees from Amazentis, Nestle, Pfizer, Rejuvenate Biomed, Embion and Hevolution Foundation, outside the submitted work. M.G. has no funding or other conflicts of interest to disclose. M.D.W. reports research grant funding from the National Institute for Health and Care Research UK and UK Research and Innovation. A.J.C.-J. has no funding to disclose. A.J.C.-J. has received honoraria for lectures or for organizing independent educational events from Abbott Nutrition, Danone-Nutricia, Nestlé Health Science and Fresenius-Kabi, and consulting fees from Akros Pharma, Chugai Pharmaceutical, Rejuvenate Biomed, Reneo Pharmaceutical and Toray Industries.
